You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美瑞健康國際(02327.HK)擬於廈門設合資負責產品新零售運營
格隆匯 12-09 22:58

格隆匯12月9日丨美瑞健康國際(02327.HK)公告,於2020年12月9日,公司通過旗下全資子公司深圳瑞麻科技有限公司與兩家中國成立的公司,分別為華彬投資(中國)有限公司及廈門萬里石股份有限公司簽訂了一份股權投資合作協議書。

根據合資協議,各方同意通過在中國廈門成立一家合資公司從事新零售業務。合資公司初定名為廈門華彬萬里新零售有限公司(具體以工商核准登記名稱為準)。合資公司志在整合各方資源,發揮協同效應,更好的促進各方相關產品通過新零售方式進行銷售。

合資公司的組織形式為中國的有限責任公司。各方認繳出資額及股權比例分別為:華彬投資出資人民幣3,000萬元,佔比60%,廈門萬里石出資人民幣1,100萬元,佔比22%,深圳瑞麻科技出資人民幣900萬元,佔比18%。

公司表示,作為集團工業大麻品牌特別是中國區域品牌運營的一部分,集團決定與華彬投資、廈門萬里石在廈門成立合資公司,負責各方相關產品的新零售運營,其中包括集團護膚品品牌—麻粧。麻粧是集團經過長期籌備推出的中國專注大麻二酚(CBD)成分的護膚品品牌。自2020年8月末,集團正式推出市場後,獲得消費者的初步認可。公司董事認為含有大麻二酚(CBD)成分的護膚品在中國有巨大的潛力。中國是全球第二大護膚品市場,市場空間巨大;大麻二酚(CBD)成分在護膚品領域有着廣泛的應用空間,根據中國政府資料顯示,在中國含有大麻二酚(CBD)成分的護膚品品牌已超過50家。公司董事相信,合資公司的設立將為集團現有護膚品銷售帶來直接的促進,從而為集團帶來新的增長機會。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account